Trade Unlisted is not regulated by the Securities and Exchange Board of India (SEBI). Investments in unlisted securities involve significant risk, including the risk of complete loss of capital. The filing of a Draft Red Herring Prospectus (DRHP) does not guarantee that an Initial Public Offering (IPO) will occur. Unlisted securities are inherently illiquid, price discovery may be limited, and exit opportunities may not materialize.
Trade Unlisted provides news, insights, and general market information for informational and educational purposes only. The content should not be construed as financial, investment, legal, or tax advice. Trade Unlisted does not act as a broker, investment advisor, fiduciary, or intermediary, and does not endorse, recommend, solicit, or validate any investment opportunity. Users are solely responsible for conducting their own independent due diligence before making any financial or investment decisions.
All information is derived from publicly available sources and market observations. While reasonable care is taken in preparing content, Trade Unlisted makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of the information provided. Users should independently verify all information prior to relying on it.
Practo, the Bengaluru-based digital healthcare platform, is in advanced discussions to raise $100 million to $125 million in a pre-IPO funding round as it prepares for a potential public listing in 2027.
Pre-IPO Fundraise Strategy
The company is reportedly exploring a mix of equity and debt financing, with participation expected from a global private equity firm along with existing investors.
The proposed round could value Practo at approximately $700 million post-money, positioning the healthtech major for a stronger balance sheet ahead of its IPO plans. Earlier timelines for listing were reportedly around 2025–26, but the company is now aiming for 2027 to consolidate growth and profitability.
Use of Funds
The fresh capital is expected to be deployed toward:
Expanding core business verticals
Strengthening product and technology capabilities
Strategic acquisitions
Scaling operations in India and international markets
The move aligns with Practo’s long-term strategy of deepening its presence across the digital healthcare ecosystem.
Company Background
Founded in 2008 by Shashank ND and Abhinav Lal, Practo started as a doctor discovery and appointment booking platform and has since evolved into a comprehensive healthcare marketplace.
The platform enables:
- Doctor consultations (online and offline)
- Diagnostic test bookings
- Medicine delivery
- Practice management software for clinics and hospitals
Beyond India, Practo has expanded into markets such as the UAE and has explored opportunities in the United States.
Financial Momentum
Practo has reportedly achieved operating EBITDA profitability in FY25, marking a significant turnaround compared to prior years. Revenue growth, improved cost efficiencies, and operational discipline have strengthened its IPO narrative.
With India’s startup ecosystem witnessing renewed IPO momentum, Practo’s proposed listing in 2027 could emerge as one of the most closely watched healthtech public offerings.
Comments